FR3117847B1 - Composition comprising aqueous gelling agents, surfactants and ascorbic acid - Google Patents
Composition comprising aqueous gelling agents, surfactants and ascorbic acid Download PDFInfo
- Publication number
- FR3117847B1 FR3117847B1 FR2013651A FR2013651A FR3117847B1 FR 3117847 B1 FR3117847 B1 FR 3117847B1 FR 2013651 A FR2013651 A FR 2013651A FR 2013651 A FR2013651 A FR 2013651A FR 3117847 B1 FR3117847 B1 FR 3117847B1
- Authority
- FR
- France
- Prior art keywords
- composition
- ascorbic acid
- surfactants
- gelling agents
- aqueous gelling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 5
- 239000004094 surface-active agent Substances 0.000 title abstract 4
- 239000011668 ascorbic acid Substances 0.000 title abstract 3
- 229960005070 ascorbic acid Drugs 0.000 title abstract 3
- 235000010323 ascorbic acid Nutrition 0.000 title abstract 3
- 239000003349 gelling agent Substances 0.000 title abstract 2
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 abstract 1
- 229920002305 Schizophyllan Polymers 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 229920001525 carrageenan Polymers 0.000 abstract 1
- 235000010418 carrageenan Nutrition 0.000 abstract 1
- 150000005690 diesters Chemical class 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 150000002314 glycerols Chemical class 0.000 abstract 1
- 239000012071 phase Substances 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
- 150000005691 triesters Chemical class 0.000 abstract 1
- 229920001285 xanthan gum Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Composition comprenant des gélifiants aqueux, des tensioactifs et de l’acide ascorbique La présente invention concerne une composition comprenant au moins une phase aqueuse gélifiée par au moins un polysaccharide non amylacé choisi parmi les gommes de scléroglucane, les gommes xanthane, les carraghénanes ou leurs mélanges; au moins une phase grasse ; au moins un tensioactif hydrophile choisi parmi les mono-, di- ou triesters de sucrose et d’acides gras, au moins un tensioactif choisi parmi les esters de glycérol ; et au moins 5 % en poids d’acide ascorbique et/ou l’un de ses dérivés, par rapport au poids total de la composition. Figure pour l’abrégé : NéantComposition comprising aqueous gelling agents, surfactants and ascorbic acid The present invention relates to a composition comprising at least one aqueous phase gelled by at least one non-starchy polysaccharide chosen from scleroglucan gums, xanthan gums, carrageenans or mixtures thereof ; at least one fatty phase; at least one hydrophilic surfactant chosen from mono-, di- or triesters of sucrose and fatty acids, at least one surfactant chosen from glycerol esters; and at least 5% by weight of ascorbic acid and/or one of its derivatives, relative to the total weight of the composition. Figure for abstract: None
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2013651A FR3117847B1 (en) | 2020-12-18 | 2020-12-18 | Composition comprising aqueous gelling agents, surfactants and ascorbic acid |
PCT/EP2021/086298 WO2022129403A1 (en) | 2020-12-18 | 2021-12-16 | Composition comprising aqueous gelling agents, surfactants and ascorbic acid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2013651A FR3117847B1 (en) | 2020-12-18 | 2020-12-18 | Composition comprising aqueous gelling agents, surfactants and ascorbic acid |
FR2013651 | 2020-12-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3117847A1 FR3117847A1 (en) | 2022-06-24 |
FR3117847B1 true FR3117847B1 (en) | 2023-11-24 |
Family
ID=74860128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR2013651A Active FR3117847B1 (en) | 2020-12-18 | 2020-12-18 | Composition comprising aqueous gelling agents, surfactants and ascorbic acid |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3117847B1 (en) |
WO (1) | WO2022129403A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024000398A1 (en) * | 2022-06-30 | 2024-01-04 | L'oreal | Composition for caring for and/or making up keratin materials |
WO2024065606A1 (en) * | 2022-09-30 | 2024-04-04 | L'oreal | Composition for caring for keratin materials |
WO2024128168A1 (en) * | 2022-12-15 | 2024-06-20 | L'oreal | Composition comprising electrolyte and combination of polysaccharides |
FR3145280A1 (en) * | 2023-01-27 | 2024-08-02 | L'oreal | COMPOSITION COMPRISING AN ELECTROLYTE AND A COMBINATION OF POLYSACCHARIDES |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3301848A (en) | 1962-10-30 | 1967-01-31 | Pillsbury Co | Polysaccharides and methods for production thereof |
ES355628A1 (en) | 1967-06-30 | 1969-12-16 | Hoffmann La Roche | The Stabilization of Ascorbic Acid and of Derivatives thereof |
JPS53127819A (en) | 1977-04-12 | 1978-11-08 | Riken Vitamin Co Ltd | Stabilization of l-asocorbic acid and its salt |
FR2581542B1 (en) | 1985-05-07 | 1988-02-19 | Oreal | TOPICAL COMPOSITIONS FOR THE TREATMENT OF SKIN BASED ON SALICYLIC ACID DERIVATIVES |
FR2607498B1 (en) | 1986-12-01 | 1991-04-05 | Oreal | NOVEL LIPOPHILIC SALICYLATES OF QUATERNARY AMMONIUMS, THEIR USE IN COSMETICS AND DERMOPHARMACY |
LU87408A1 (en) | 1988-12-16 | 1990-07-10 | Oreal | USE OF SALICYL DERIVATIVES FOR THE TREATMENT OF AGING SKIN |
US5140043A (en) | 1989-04-17 | 1992-08-18 | Duke University | Stable ascorbic acid compositions |
JP2832848B2 (en) | 1989-10-21 | 1998-12-09 | 株式会社林原生物化学研究所 | Crystal 2-O-α-D-glucopyranosyl-L-ascorbic acid, its production method and use |
BR9001880A (en) | 1990-04-18 | 1991-11-12 | Forjas Taurus Sa | DOG DISARMING MECHANISM APPLICABLE TO SEMI-AUTOMATIC PISTOLS |
TW197375B (en) | 1990-11-19 | 1993-01-01 | Hayashibara Biochem Lab | |
DE69321285T2 (en) | 1992-05-15 | 1999-03-04 | Shiseido Co. Ltd., Tokio/Tokyo | External skin preparation |
FR2714831B1 (en) | 1994-01-10 | 1996-02-02 | Oreal | Cosmetic and / or dermatological composition containing salicylic acid derivatives and method for solubilizing these derivatives. |
FR2726468B1 (en) | 1994-11-03 | 1996-12-13 | Oreal | USE OF SALICYLIC ACID DERIVATIVE AS AN OIL-IN-WATER EMULSION STABILIZER |
US5762789A (en) | 1996-06-28 | 1998-06-09 | Millipore Corporation | Disposable membrane module with low-dead volume |
US5750123A (en) | 1996-06-28 | 1998-05-12 | Chesebrough-Pond's Co., Division Of Conopco, Inc. | Vitamin C delivery system |
US6159479A (en) | 1997-09-16 | 2000-12-12 | L'oreal | Hydrous salicylic acid solutions |
CN1356888A (en) * | 1998-11-13 | 2002-07-03 | 宝洁公司 | Oil-in-water emulsion contg. ascorbic acid compound |
FR2818547B1 (en) | 2000-12-22 | 2006-11-17 | Oreal | NOVEL C-GLYCOSIDE DERIVATIVES AND USE |
US7488841B2 (en) | 2002-08-27 | 2009-02-10 | Asahi Kasei Chemicals Corporation | Composition containing acyl group |
WO2008155059A2 (en) | 2007-06-19 | 2008-12-24 | Cognis Ip Management Gmbh | Hydrocarbon mixtures and use thereof |
-
2020
- 2020-12-18 FR FR2013651A patent/FR3117847B1/en active Active
-
2021
- 2021-12-16 WO PCT/EP2021/086298 patent/WO2022129403A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2022129403A1 (en) | 2022-06-23 |
FR3117847A1 (en) | 2022-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR3117847B1 (en) | Composition comprising aqueous gelling agents, surfactants and ascorbic acid | |
FR3117803B1 (en) | Composition comprising aqueous gelling agents, surfactant and ascorbic acid | |
US8685942B2 (en) | Sophorolipid analog compositions | |
CZ289570B6 (en) | Pharmaceutical formulation containing voriconazole | |
JP4762718B2 (en) | Prostaglandin-containing pharmaceutical composition | |
KR20070094793A (en) | Stable prostaglandin-containing compositions | |
JPH08175974A (en) | Ophthalmic solution | |
FR3044900A1 (en) | ||
FR3098401B1 (en) | Solid cosmetic cleanser | |
JP4215277B2 (en) | Preservative system for pharmaceutical compositions containing cyclodextrin | |
FR2958647A1 (en) | POLYSACCHARIDES COMPRISING CARBOXYL FUNCTIONAL GROUPS SUBSTITUTED WITH A HYDROPHOBIC DERIVATIVE CARRIED BY AT LEAST TRIVALENT SPACER. | |
FI3506935T3 (en) | Neisseria meningitidis vaccine | |
EP0435682A2 (en) | The use of inclusion complexes of prostaglandins with cyclodextrins in the treatment of ocular hypertension | |
CN104224704A (en) | Aqueous composition | |
FR3044922A1 (en) | ||
KR920007570B1 (en) | Fervescence composition | |
CA2427375A1 (en) | Pharmaceutical dronedarone composition for parenteral administration | |
DE4239877C1 (en) | Stabilized superoxide dismutase (SOD) composition | |
FR3098400B1 (en) | Solid hair cosmetic composition | |
DE69031321D1 (en) | Fabric softening compositions | |
FR3105735B1 (en) | Composition comprising ascorbic acid | |
MXPA02009915A (en) | Bile secretion promoting composition. | |
FR2788436A1 (en) | Composition useful for treating allergic rhinitis contains phenothiazine derivative in aqueous stabilized with sulfur-containing amino acid derivative | |
FR2852959A1 (en) | NOVEL CYCLODEXTRIN DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND THEIR USE IN PARTICULAR FOR SOLUBILIZING PHARMACOLOGICALLY ACTIVE SUBSTANCES | |
TW210287B (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20220624 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |